
Opinion|Videos|April 11, 2024
Cost-Effectiveness Metrics Payers Seek for Digital Therapeutics
Diana Brixner, PhD, FAMCP, examines the payer perspective on including Prescription Digital Therapeutics in formularies, utilizing real-world evidence as a key metric to assess the impact, cost-effectiveness, and patient benefit of these innovative digital treatments.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers discover new pathway to fight liver inflammation
2
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
3
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
4
FDA approves $2.7 million gene therapy for rare metabolic disorder
5



















